Surveillance for Barrett's oesophagus. The conundrum of Barrett's oesophagus is changing.
作者信息
Eksteen J A, Jankowski J A
出版信息
BMJ. 2001 May 5;322(7294):1124-5; author reply 1126.
Abstract
摘要
相似文献
1
Surveillance for Barrett's oesophagus. The conundrum of Barrett's oesophagus is changing.
BMJ. 2001 May 5;322(7294):1124-5; author reply 1126.
2
Surveillance for Barrett's oesophagus. It is too early to dismiss surveillance programmes.
BMJ. 2001 May 5;322(7294):1125; author reply 1126.
3
Surveillance for Barrett's oesophagus. Appropriate practice must be studied.
BMJ. 2001 May 5;322(7294):1125-6.
4
Surveillance for Barrett's oesophagus. Patients need to be appropriately selected for follow up.
BMJ. 2001 May 5;322(7294):1125; author reply 1126.
5
New developments in the endoscopic surveillance of Barrett's oesophagus.
Gut. 2005 Mar;54 Suppl 1(Suppl 1):i38-42. doi: 10.1136/gut.2004.041590.
6
Barrett's oesophagus: diagnosis and management.
Baillieres Best Pract Res Clin Gastroenterol. 2000 Oct;14(5):857-79. doi: 10.1053/bega.2000.0129.
7
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
Gut. 2010 Aug;59(8):1030-6. doi: 10.1136/gut.2009.176701.
8
Are screening and surveillance for Barrett's oesophagus really worthwhile?
Gut. 2005 Mar;54 Suppl 1(Suppl 1):i27-32. doi: 10.1136/gut.2004.041566.
9
[Surveillance for Barrett's oesophagus: worthwhile?].
Ned Tijdschr Geneeskd. 2012;156(49):A5497.
10
A surveillance programme for Barrett's oesophagus in a UK general hospital.
Eur J Gastroenterol Hepatol. 2007 Apr;19(4):305-9. doi: 10.1097/01.meg.0000252630.96043.b1.
引用本文的文献
1
Neoadjuvant treatment of esophageal cancer.
World J Gastroenterol. 2010 Aug 14;16(30):3793-803. doi: 10.3748/wjg.v16.i30.3793.
本文引用的文献
1
Barrett's metaplasia.
Lancet. 2000 Dec 16;356(9247):2079-85. doi: 10.1016/S0140-6736(00)03411-5.
2
Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.
BMJ. 2000 Nov 18;321(7271):1252-5. doi: 10.1136/bmj.321.7271.1252.
3
Barrett's oesophagus: the continuing conundrum.
BMJ. 2000 Nov 18;321(7271):1238-9. doi: 10.1136/bmj.321.7271.1238.
4
Gastro-oesophageal cancer: death at the junction.
BMJ. 2000;321(7259):463-4. doi: 10.1136/bmj.321.7259.463.
5
Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
J Natl Cancer Inst. 2000 Aug 16;92(16):1316-21. doi: 10.1093/jnci/92.16.1316.
6
Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus.
Scand J Gastroenterol. 2000 Jan;35(1):10-6.
7
Management of Barrett's esophagus: a national study of practice patterns and their cost implications.
Am J Gastroenterol. 1999 Dec;94(12):3440-7. doi: 10.1111/j.1572-0241.1999.01606.x.
8
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
Am J Pathol. 1999 Apr;154(4):965-73. doi: 10.1016/S0002-9440(10)65346-1.
9
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.
Am J Gastroenterol. 1998 Jul;93(7):1028-32. doi: 10.1111/j.1572-0241.1998.00362.x.
10
Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Am J Gastroenterol. 1998 Jun;93(6):911-5. doi: 10.1111/j.1572-0241.1998.00275.x.
Zotero 插件